By Robb M. Stewart
Cosciens Biopharma appointed Anna Biehn as the specialty biopharmaceutical company's next chief executive, turning to an executive with more than 25 years experience in the consumer products and biosciences industries.
Biehn will take up the post May 5, succeeding Gilles Gagnon, who will remain with the Canadian company as a strategic adviser and director, Cosciens said Monday.
Biehn most recently served as the chief financial officer of NuTek Natural Ingredients, a "clean-label" and plant-based food ingredient company. Prior to her position s CFO, Biehn was vice president of strategy and marketing. She began her career at packaged food company Conagra, where she held a number of roles including as president responsible for leading the company's international business.
Gagnon last September said Cosciens' board had hired an executive recruiting firm to help identify the company's next president and CEO.
Cosciens, which was created with last year's all-stock merger of Aeterna Zentaris and Ceapro, develops and commercializes a portfolio of what it describes as cosmeceutical, nutraceutical and pharmaceutical products.
Write to Robb M. Stewart at robb.stewart@wsj.com
(END) Dow Jones Newswires
April 14, 2025 07:26 ET (11:26 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。